Immunophenotypic analysis of myelodysplastic syndromes.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
2001 • 334 citations
Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome
2001 • 292 citations
Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients
1997 • 271 citations
A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies
2000 • 125 citations
Immunophenotypic clustering of myelodysplastic syndromes
2002 • 122 citations
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
1999 • 122 citations
Surface marker abnormalities in myelodysplastic syndromes.
1998 • 75 citations
The molecular basis of myelodysplastic syndromes.
1997 • 67 citations
Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns
1990 • 64 citations
Detection of abnormalities in B‐cell differentiation pattern is a useful tool to predict relapse in precursor‐B‐ALL
1999 • 53 citations
Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis
1987 • 47 citations
Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes
1990 • 41 citations
High la (HLA‐DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes
1993 • 25 citations
Immunotyping of blasts in refractory anaemia with excess of blasts
1993 • 19 citations
CD34 Immunophenotyping of Blasts in Myelodysplasia
1994 • 7 citations
Cited By (0)
No citing papers found in database